Development of an Automated Liquid Biopsy Assay for Methylated Markers in Advanced Breast Cancer

Current molecular liquid biopsy assays to detect recurrence or monitor response to treatment require sophisticated technology, highly trained personnel, and a turnaround time of weeks. We describe the development and technical validation of an automated Liquid Biopsy for Breast Cancer Methylation (L...

Descripción completa

Detalles Bibliográficos
Autores principales: Fackler, Mary Jo, Tulac, Suzana, Venkatesan, Neesha, Aslam, Adam J., de Guzman, Timothy N., Mercado-Rodriguez, Claudia, Cope, Leslie M., Downs, Bradley M., Vali, Abdul Hussain, Ding, Wanjun, Lehman, Jennifer, Denbow, Rita, Reynolds, Jeffrey, Buckley, Morgan E., Visvanathan, Kala, Umbricht, Christopher B., Wolff, Antonio C., Stearns, Vered, Bates, Michael, Lai, Edwin W., Sukumar, Saraswati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426415/
https://www.ncbi.nlm.nih.gov/pubmed/36046124
http://dx.doi.org/10.1158/2767-9764.CRC-22-0133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426415/
https://www.ncbi.nlm.nih.gov/pubmed/36046124
http://dx.doi.org/10.1158/2767-9764.CRC-22-0133

Ejemplares similares